- Gene expression
Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product. These products are often proteins, but in non-protein coding genes such as ribosomal RNA (rRNA), transfer RNA (tRNA) or small nuclear RNA (snRNA) genes, the product is a functional RNA. The process of gene expression is used by all known life - eukaryotes (including multicellular organisms), prokaryotes (bacteria and archaea), possibly induced by viruses - to generate the macromolecular machinery for life. Several steps in the gene expression process may be modulated, including the transcription, RNA splicing, translation, and post-translational modification of a protein. Gene regulation gives the cell control over structure and function, and is the basis for cellular differentiation, morphogenesis and the versatility and adaptability of any organism. Gene regulation may also serve as a substrate for evolutionary change, since control of the timing, location, and amount of gene expression can have a profound effect on the functions (actions) of the gene in a cell or in a multicellular organism.
In genetics, gene expression is the most fundamental level at which the genotype gives rise to the phenotype. The genetic code stored in DNA is "interpreted" by gene expression, and the properties of the expression give rise to the organism's phenotype.
- 1 Mechanism
- 2 Regulation of gene expression
- 3 Measurement
- 4 Expression system
- 5 Gene networks
- 6 Techniques and tools
- 7 See also
- 8 References
- 9 External links
The gene itself is typically a long stretch of DNA which carries genetic information encoded by genetic code. Every molecule of DNA consists of two strands, each of them having 5' and 3' ends oriented in anti-parallel direction. The coding strand contains the genetic information while template strand (non-coding strand) serves as a blueprint for the production of RNA. The production of RNA copies of the DNA is called transcription, and is performed by RNA polymerase, which adds one RNA nucleotide at a time to a growing RNA strand. This RNA is complementary to the template 3' → 5' DNA strand, which is itself complementary to the coding 5' → 3' DNA strand. Therefore, the resulting 5' → 3' RNA strand is identical to the coding DNA strand with the exception that thymines (T) are replaced with uracils (U) in the RNA. A coding DNA strand reading "ATG" is transcribed as "AUG" in RNA.
Transcription in prokaryotes is carried out by a single type of RNA polymerase, which needs DNA sequence called Pribnow box and sigma factor (σ factor) to start transcription. In eukaryotes, the transcription is done by three types of RNA polymerases, each of them needs special DNA sequence called promoter and a set of DNA-binding proteins - transcription factors to initiate the process. RNA polymerase I is responsible for transcription of rRNA genes, while RNA polymerase II transcribes all protein-coding genes but also some non-coding RNAs (e.g. snRNAs, snoRNAs or long non-coding RNAs) as well. It contains special part called C-terminal domain (CTD) that is rich of serines, which after being phosphorylated accumulate factors necessary for RNA modification and maturation. RNA polymerase III transcribes 5S rRNA and tRNA genes but also some small non-coding RNA genes (e.g. 7SK). Transcription ends on a special sequence called terminator.
While transcription of prokaryotic protein-coding genes creates messenger RNA (mRNA) which is ready for translation, transcription of eukaryotic genes leaves a primary transcript of RNA (pre-mRNA), which first has to undergo series of modification to become a mature mRNA.
These include 5' capping, which is set of enzymatic reactions that add 7-methylguanosine (m7G) to the 5' end of pre-mRNA and thus protect the RNA from degradation by exonucleases. The m7G cap is then bound by cap binding complex heterodimer (CBC20/CBC80) which aids in mRNA export to cytoplasm and also protect the RNA from decapping.
Another modification is 3' cleavage and polyadenylation. They occur if polyadenylation signal sequence (5'- AAUAAA-3') is present in pre-mRNA,which is usually between protein-coding sequence and terminator. The pre-mRNA is first cleaved and then a series of ~200 adenines (A) are added to form poly(A) tail which protects the RNA from degradation. Poly(A) tail is bound by multiple poly(A)-binding proteins (PABP) necessary for mRNA export and translation re-initiation.
Very important modification of eukaryotic pre-mRNA is RNA splicing. Majority of eukaryotic pre-mRNAs consist of alternating segments called exons and introns. During the process of splicing, RNA-protein catalytical complex known as spliceosome, catalyze two transesterification reactions, which remove intron and release it in form of lariat structure and then splice neighbouring exons together. In certain cases, some introns or exons can be either removed or retained in mature mRNA. This so-called alternative splicing creates series of different transcripts originating from a single gene. Because these transcripts can be potentially translated into different proteins, splicing extends the complexity of eukaryotic gene expression.
Extensive RNA processing may be an evolutionary advantage made possible by the nucleus of eukaryotes. In prokaryotes transcription and translation happen together whilst in eukaryotes the nuclear membrane separates the two processes giving time for RNA processing to occur.
non-coding RNA maturation
In most organisms non-coding genes (ncRNA) are transcribed as precursors which undergo further processing. In the case of ribosomal RNAs (rRNA), they are often transcribed as a pre-rRNA which contains one or more rRNAs, the pre-rRNA is cleaved and modified (2′-O-methylation and pseudouridine formation) at a specific sites by approximately 150 different small nucleolus-restricted RNA species, called snoRNAs. SnoRNAs associate with proteins, forming snoRNPs. While snoRNA part basepair with the target RNA and thus position the modification to precise site, the protein part performs the catalytical reaction. In eukaryotes, in particular a snoRNP, called RNase MRP cleaves the 45S pre-rRNA into the 28S, 5.8S, and 18S rRNAs. The rRNA and RNA processing factors form large aggregates called the nucleolus.
In the case of transfer RNA (tRNA), for example, the 5' sequence is removed by RNase P, whereas the 3' end is removed by the tRNase Z enzyme and the non-templated 3' CCA tail is added by a nucleotidyl transferase. In the case of micro RNA (miRNA), miRNAs are first transcribed as primary transcripts or pri-miRNA with a cap and poly-A tail and processed to short, 70-nucleotide stem-loop structures known as pre-miRNA in the cell nucleus by the enzymes Drosha and Pasha. After being exported, it is then processed to mature miRNAs in the cytoplasm by interaction with the endonuclease Dicer, which also initiates the formation of the RNA-induced silencing complex (RISC), composed of the Argonaute protein.
Even snRNAs and snoRNAs themselves undergo series of modification before they become part of functional RNP complex. This is done either in the nucleoplasm or in the specialized compartments called Cajal bodies. Their bases are methylated or pseudouridinilated by a group of small Cajal body-specific RNAs (scaRNAs) which are structurally similar to snoRNAs.
In eukaryotes most mature RNA must be exported to the cytoplasm from the nucleus. While some RNAs function in the nucleus, many RNAs are transported through the nuclear pores and into the cytosol. Notably this includes all RNA types involved in protein synthesis. In some cases RNAs are additionally transported to a specific part of the cytoplasm, such as a synapse; they are then towed by motor proteins that bind through linker proteins to specific sequences (called "zipcodes") on the RNA.
For some RNA (non-coding RNA) the mature RNA is the final gene product. In the case of messenger RNA (mRNA) the RNA is an information carrier coding for the synthesis of one or more proteins. mRNA carrying a single protein sequence (common in eukaryotes) is monocistronic whilst mRNA carrying multiple protein sequences (common in prokaryotes) is known as polycistronic.
Every mRNA consists of three parts - 5' untranslated region (5'UTR), protein-coding region or open reading frame (ORF) and 3' untranslated region (3'UTR). Coding region carries information for protein synthesis encoded by genetic code into form of triplets. Each triplet of nucleotides of the coding region is called codon and corresponds to a binding site complementary to an anticodon triplet in transfer RNA. Transfer RNAs with the same anticodon sequence always carry identical type of amino acid. Amino acids are then chained together by the ribosome according to order of triplets in the coding region. The ribosome helps transfer RNA to bind to messenger RNA and takes the amino acid from each transfer RNA and makes a structure-less protein out of it. Each mRNA molecule is translated into many protein molecules, on average ~900 in mammals.
In prokaryotes translation generally occurs at the point of transcription (co-transcriptionally), often using a messenger RNA which is still in the process of being created. In eukaryotes translation can occur in a variety of regions of the cell depending on where the protein being written is supposed to be. Major locations are the cytoplasm for soluble cytoplasmic proteins and the membrane of endoplasmic reticulum for proteins which are for export from the cell or insertion into a cell membrane. Proteins which are supposed to be expressed at the endoplasmic reticulum are recognised part-way through the translation process. This is governed by the signal recognition particle - a protein which binds to the ribosome and directs it to the endoplasmic reticulum when it finds a signal sequence on the growing (nascent) amino acid chain.
The polypeptide folds into its characteristic and functional three-dimensional structure from random coil. Each protein exists as an unfolded polypeptide or random coil when translated from a sequence of mRNA to a linear chain of amino acids. This polypeptide lacks any developed three-dimensional structure (the left hand side of the neighboring figure). Amino acids interact with each other to produce a well-defined three-dimensional structure, the folded protein (the right hand side of the figure), known as the native state. The resulting three-dimensional structure is determined by the amino acid sequence (Anfinsen's dogma).
The correct three-dimensional structure is essential to function, although some parts of functional proteins may remain unfolded Failure to fold into the intended shape usually produces inactive proteins with different properties including toxic prions. Several neurodegenerative and other diseases are believed to result from the accumulation of misfolded (incorrectly folded) proteins. Many allergies are caused by the folding of the proteins, for the immune system does not produce antibodies for certain protein structures.
Enzymes called chaperones assist the newly formed protein to attain (fold into) the 3-dimensional structure it needs to function. Similarly, RNA chaperones help RNAs attain their functional shapes. Assisting protein folding is one of the main roles of the endoplasmic reticulum in eukaryotes.
Many proteins are destined for other parts of the cell than the cytosol and a wide range of signalling sequences are used to direct proteins to where they are supposed to be. In prokaryotes this is normally a simple process due to limited compartmentalisation of the cell. However in eukaryotes there is a great variety of different targeting processes to ensure the protein arrives at the correct organelle.
Not all proteins remain within the cell and many are exported, for example digestive enzymes, hormones and extracellular matrix proteins. In eukaryotes the export pathway is well developed and the main mechanism for the export of these proteins is translocation to the endoplasmic reticulum, followed by transport via the Golgi apparatus.
Regulation of gene expression
Regulation of gene expression refers to the control of the amount and timing of appearance of the functional product of a gene. Control of expression is vital to allow a cell to produce the gene products it needs when it needs them; in turn this gives cells the flexibility to adapt to a variable environment, external signals, damage to the cell, etc. Some simple examples of where gene expression is important are:
- Control of insulin expression so it gives a signal for blood glucose regulation
- X chromosome inactivation in female mammals to prevent an "overdose" of the genes it contains.
- Cyclin expression levels control progression through the eukaryotic cell cycle
More generally gene regulation gives the cell control over all structure and function, and is the basis for cellular differentiation, morphogenesis and the versatility and adaptability of any organism.
Any step of gene expression may be modulated, from the DNA-RNA transcription step to post-translational modification of a protein. The stability of the final gene product, whether it is RNA or protein, also contributes to the expression level of the gene - an unstable product results in a low expression level. In general gene expression is regulated through changes in the number and type of interactions between molecules that collectively influence transcription of DNA and translation of RNA.
Numerous terms are used to describe types of genes depending on how they are regulated, these include:
- A constitutive gene is a gene that is transcribed continually compared to a facultative gene which is only transcribed when needed.
- A housekeeping gene is typically a constitutive gene that is transcribed at a relatively constant level. The housekeeping gene's products are typically needed for maintenance of the cell. It is generally assumed that their expression is unaffected by experimental conditions. Examples include actin, GAPDH and ubiquitin.
- A facultative gene is a gene which is only transcribed when needed compared to a constitutive gene.
- An inducible gene is a gene whose expression is either responsive to environmental change or dependent on the position in the cell cycle.
Regulation of transcription can be broken down into three main routes of influence; genetic (direct interaction of a control factor with the gene), modulation (interaction of a control factor with the transcription machinery) and epigenetic (non-sequence changes in DNA structure which influence transcription).
Direct interaction with DNA is the simplest and the most direct method by which a protein can change transcription levels. Genes often have several protein binding sites around the coding region with the specific function of regulating transcription. There are many classes of regulatory DNA binding sites known as enhancers, insulators, repressors and silencers. The mechanisms for regulating transcription are very varied, from blocking key binding sites on the DNA for RNA polymerase to acting as an activator and promoting transcription by assisting RNA polymerase binding.
The activity of transcription factors is further modulated by intracellular signals causing protein post-translational modification including phosphorylated, acetylated, or glycosylated. These changes influence a transcription factor's ability to bind, directly or indirectly, to promoter DNA, to recruit RNA polymerase, or to favor elongation of a newly synthetized RNA molecule.
The nuclear membrane in eukaryotes allows further regulation of transcription factors by the duration of their presence in the nucleus which is regulated by reversible changes in their structure and by binding of other proteins. Environmental stimuli or endocrine signals may cause modification of regulatory proteins eliciting cascades of intracellular signals, which result in regulation of gene expression.
More recently it has become apparent that there is a huge influence of non-DNA-sequence specific effects on translation. These effects are referred to as epigenetic and involve the higher order structure of DNA, non-sequence specific DNA binding proteins and chemical modification of DNA. In general epigenetic effects alter the accessibility of DNA to proteins and so modulate transcription.
DNA methylation is a widespread mechanism for epigenetic influence on gene expression and is seen in bacteria and eukaryotes and has roles in heritable transcription silencing and transcription regulation. In eukaryotes the structure of chromatin, controlled by the histone code, regulates access to DNA with significant impacts on the expression of genes in euchromatin and heterochromatin areas.
In eukaryotes, where export of RNA is required before translation is possible, nuclear export is thought to provide additional control over gene expression. All transport in and out of the nucleus is via the nuclear pore and transport is controlled by a wide range of importin and exportin proteins.
Expression of a gene coding for a protein is only possible if the messenger RNA carrying the code survives long enough to be translated. In a typical cell an RNA molecule is only stable if specifically protected from degradation. RNA degradation has particular importance in regulation of expression in eukaryotic cells where mRNA has to travel significant distances before being translated. In eukaryotes RNA is stabilised by certain post-transcriptional modifications, particularly the 5' cap and poly-adenylated tail.
Intentional degradation of mRNA is used not just as a defence mechanism from foreign RNA (normally from viruses) but also as a route of mRNA destabilisation. If an mRNA molecule has a complementary sequence to a small interfering RNA then it is targeted for destruction via the RNA interference pathway.
Direct regulation of translation is less prevalent than control of transcription or mRNA stability but is occasionally used. Inhibition of protein translation is a major target for toxins and antibiotics in order to kill a cell by overriding its normal gene expression control. Protein synthesis inhibitors include the antibiotic neomycin and the toxin ricin.
Once protein synthesis is complete the level of expression of that protein can be reduced by protein degradation. There are major protein degradation pathways in all prokaryotes and eukaryotes of which the proteasome is a common component. An unneeded or damaged protein is often labelled for degradation by addition of ubiquitin.
Measuring gene expression is an important part of many life sciences - the ability to quantify the level at which a particular gene is expressed within a cell, tissue or organism can give a huge amount of information. For example measuring gene expression can:
- Identify viral infection of a cell (viral protein expression)
- Determine an individual's susceptibility to cancer (oncogene expression)
- Find if a bacterium is resistant to penicillin (beta-lactamase expression)
Similarly the analysis of the location of expression protein is a powerful tool and this can be done on an organism or cellular scale. Investigation of localisation is particularly important for study of development in multicellular organisms and as an indicator of protein function in single cells. Ideally measurement of expression is done by detecting the final gene product (for many genes this is the protein) however it is often easier to detect one of the precursors, typically mRNA, and infer gene expression level.
Levels of mRNA can be quantitatively measured by northern blotting which gives size and sequence information about the mRNA molecules. A sample of RNA is separated on an agarose gel and hybridized to a radio-labeled RNA probe that is complementary to the target sequence. The radio-labeled RNA is then detected by an autoradiograph. The main problems with Northern blotting stem from the use of radioactive reagents (which make the procedure time consuming and potentially dangerous) and lower quality quantification than more modern methods (due to the fact that quantification is done by measuring band strength in an image of a gel). Northern blotting is, however, still widely used as the additional mRNA size information allows the discrimination of alternately spliced transcripts.
A more modern low-throughput approach for measuring mRNA abundance is reverse transcription quantitative polymerase chain reaction (RT-PCR followed with qPCR). RT-PCR first generates a DNA template from the mRNA by reverse transcription, which is called cDNA. This cDNA template is then used for qPCR where the change in fluorescence of a probe changes as the DNA amplification process progresses. With a carefully constructed standard curve qPCR can produce an absolute measurement such as number of copies of mRNA, typically in units of copies per nanolitre of homogenized tissue or copies per cell. qPCR is very sensitive (detection of a single mRNA molecule is possible), but can be expensive due to the fluorescent probes required.
An even more advanced approach is to individually tag single mRNA molecules with fluorescent barcodes (nanostrings), which can be detected one-by-one and counted for direct digital quantification. The advantage of this approach is that it does not rely on analog quantification of fluorescent intensity, which can be problematic due to noise, lack of linearity, and narrow dynamic range. Instead, the technique relies on fluorescence to detect simply the presence of a single mRNA molecule in a binary ("yes" or "no") mode. This method was invented by Dr. Krassen Dimitrov at the Institute for Systems Biology and commercialized through his start-up company, NanoString Technologies
Northern blots and RT-qPCR are good for detecting whether a single gene is being expressed, but it quickly becomes impractical if many genes within the sample are being studied. Using DNA microarrays, transcript levels for many genes at once (expression profiling) can be measured. Recent advances in microarray technology allow for the quantification, on a single array, of transcript levels for every known gene in several organism's genomes, including humans.
Alternatively "tag based" technologies like Serial analysis of gene expression (SAGE), which can provide a relative measure of the cellular concentration of different mRNAs, can be used. The great advantage of tag-based methods is the "open architecture", allowing for the exact measurement of any transcript, with a known or unknown sequence.
For genes encoding proteins the expression level can be directly assessed by a number of means with some clear analogies to the techniques for mRNA quantification.
The most commonly used method is to perform a Western blot against the protein of interest - this gives information on the size of the protein in addition to its identity. A sample (often cellular lysate) is separated on a polyacrylamide gel, transferred to a membrane and then probed with an antibody to the protein of interest. The antibody can either be conjugated to a fluorophore or to horseradish peroxidase for imaging and/or quantification. The gel-based nature of this assay makes quantification less accurate but it has the advantage of being able to identify later modifications to the protein, for example proteolysis or ubiquitination, from changes in size.
Analysis of expression is not limited to only quantification; localisation can also be determined. mRNA can be detected with a suitably labelled complementary mRNA strand and protein can be detected via labelled antibodies. The probed sample is then observed by microscopy to identify where the mRNA or protein is.
By replacing the gene with a new version fused a green fluorescent protein (or similar) marker expression may be directly quantified in live cells. This is done by imaging using a fluorescence microscope. It is very difficult to clone a GFP-fused protein into its native location in the genome without affecting expression levels so this method often cannot be used to measure endogenous gene expression. It is, however, widely used to measure the expression of a gene artificially introduced into the cell, for example via an expression vector. It is important to note that by fusing a target protein to a fluorescent reporter the protein's behavior, including its cellular localization and expression level, can be significantly changed.
The enzyme-linked immunosorbent assay works by using antibodies immobilised on a microtiter plate to capture proteins of interest from samples added to the well. Using a detection antibody conjugated to an enzyme or fluorophore the quantity of bound protein can be accurately measured by fluorometric or colourimetric detection. The detection process is very similar to that of a Western blot, but by avoiding the gel steps more accurate quantification can be achieved.
An expression system is a system specifically designed for the production of a gene product of choice. This is normally a protein although may also be RNA, such as tRNA or a ribozyme. An expression system consists of a gene, normally encoded by DNA, and the molecular machinery required to transcribe the DNA into mRNA and translate the mRNA into protein using the reagents provided. In the broadest sense this includes every living cell but the term is more normally used to refer to expression as a laboratory tool. An expression system is therefore often artificial in some manner. Expression systems are, however, a fundamentally natural process. Viruses are an excellent example where they replicate by using the host cell as an expression system for the viral proteins and genome.
Doxycycline is also used in "Tet-on" and "Tet-off" tetracycline controlled transcriptional activation to regulate transgene expression in organisms and cell cultures
In addition to these biological tools, certain naturally observed configurations of DNA (genes, promoters, enhancers, repressors) and the associated machinery itself are referred to as an expression system. This term is normally used in the case where a gene or set of genes is switched on under well defined conditions. For example the simple repressor switch expression system in Lambda phage and the lac operator system in bacteria. Several natural expression systems are directly used or modified and used for artificial expression systems such as the Tet-on and Tet-off expression system.
Genes have sometimes been regarded as nodes in a network, with inputs being proteins such as transcription factors, and outputs being the level of gene expression. The node itself performs a function, and the operation of these functions have been interpreted as performing a kind of information processing within cell and determine cellular behavior.
Gene networks can also be constructed without formulating an explicit causal model. This is often the case when assembling networks from large expression data sets. Covariation and correlation of expression is computed across a large sample of cases and measurements (often transcriptome or proteome data). The source of variation can be either experimental or natural (observational). There are several ways to construct gene expression networks, but one common approach is to compute a matrix of all pair-wise correlations of expression across conditions, time points, or individuals and convert the matrix (after thresholding at some cut-off value) into a graphical representation in which nodes represent genes, transcripts, or proteins and edges connecting these nodes represent the strength of association (see ).
Techniques and tools
The following experimental techniques are used to measure gene expression and are listed in roughly chronological order, starting with the older, more established technologies. They are divided into two groups based on their degree of multiplexity.
- Low-to-mid-plex techniques:
- Transcriptional noise
- Transcriptional bursting
- Expression profiling
- Expressed sequence tag
- Sequence profiling tool
- Genetically modified organism
- Genetic engineering
- List of human genes
- Oscillating gene
- AlloMap Molecular Expression Testing
- ^ Brueckner F, Armache KJ, Cheung A, et al (February 2009). "Structure–function studies of the RNA polymerase II elongation complex". Acta Crystallogr. D Biol. Crystallogr. 65 (Pt 2): 112–20. doi:10.1107/S0907444908039875. PMC 2631633. PMID 19171965. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2631633.
- ^ Sirri V, Urcuqui-Inchima S, Roussel P, Hernandez-Verdun D (January 2008). "Nucleolus: the fascinating nuclear body". Histochem. Cell Biol. 129 (1): 13–31. doi:10.1007/s00418-007-0359-6. PMC 2137947. PMID 18046571. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2137947.
- ^ Frank DN, Pace NR (1998). "Ribonuclease P: unity and diversity in a tRNA processing ribozyme". Annu. Rev. Biochem. 67: 153–80. doi:10.1146/annurev.biochem.67.1.153. PMID 9759486.
- ^ Ceballos M, Vioque A (2007). "tRNase Z". Protein Pept. Lett. 14 (2): 137–45. doi:10.2174/092986607779816050. PMID 17305600.
- ^ Weiner AM (October 2004). "tRNA maturation: RNA polymerization without a nucleic acid template". Curr. Biol. 14 (20): R883–5. doi:10.1016/j.cub.2004.09.069. PMID 15498478.
- ^ Köhler A, Hurt E (October 2007). "Exporting RNA from the nucleus to the cytoplasm". Nat. Rev. Mol. Cell Biol. 8 (10): 761–73. doi:10.1038/nrm2255. PMID 17786152.
- ^ Jambhekar A, Derisi JL (May 2007). "Cis-acting determinants of asymmetric, cytoplasmic RNA transport". RNA 13 (5): 625–42. doi:10.1261/rna.262607. PMC 1852811. PMID 17449729. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1852811.
- ^ Amaral PP, Dinger ME, Mercer TR, Mattick JS (March 2008). "The eukaryotic genome as an RNA machine". Science 319 (5871): 1787–9. doi:10.1126/science.1155472. PMID 18369136.
- ^ Hansen TM, Baranov PV, Ivanov IP, Gesteland RF, Atkins JF (May 2003). "Maintenance of the correct open reading frame by the ribosome". EMBO Rep. 4 (5): 499–504. doi:10.1038/sj.embor.embor825. PMC 1319180. PMID 12717454. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1319180.
- ^ Berk V, Cate JH (June 2007). "Insights into protein biosynthesis from structures of bacterial ribosomes". Curr. Opin. Struct. Biol. 17 (3): 302–9. doi:10.1016/j.sbi.2007.05.009. PMID 17574829.
- ^ Schwanhäusser B, Busse D, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M (2011). "Global quantification of mammalian gene expression control". Nature 473 (7347): 337–42. doi:10.1038/nature10098. PMID 21593866.
- ^ Hegde RS, Kang SW (July 2008). "The concept of translocational regulation". J. Cell Biol. 182 (2): 225–32. doi:10.1083/jcb.200804157. PMC 2483521. PMID 18644895. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2483521.
- ^ Alberts, Bruce; Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, and Peter Walters (2002). "The Shape and Structure of Proteins". Molecular Biology of the Cell; Fourth Edition. New York and London: Garland Science. ISBN 0-8153-3218-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&db=books&doptcmdl=GenBookHL&term=mboc4%5Bbook%5D+AND+372270%5Buid%5D&rid=mboc4.section.388.
- ^ Anfinsen, C. (1972). "The formation and stabilization of protein structure". Biochem. J. 128 (4): 737–49. PMC 1173893. PMID 4565129. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1173893.
- ^ Jeremy M. Berg, John L. Tymoczko, Lubert Stryer; Web content by Neil D. Clarke (2002). "3. Protein Structure and Function". Biochemistry. San Francisco: W. H. Freeman. ISBN 0-7167-4684-0. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&db=books&doptcmdl=GenBookHL&term=stryer%5Bbook%5D+AND+215168%5Buid%5D&rid=stryer.chapter.280.
- ^ Dennis J. Selkoe (2003). "Folding proteins in fatal ways". Nature 426 (6968): 900–904. doi:10.1038/nature02264. PMID 14685251. http://www.nature.com/nature/journal/v426/n6968/full/nature02264.html.
- ^ Alberts, Bruce, Dennis Bray, Karen Hopkin, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, and Peter Walter. "Protein Structure and Function." Essential Cell Biology. Edition 3. New York: Garland Science, Taylor and Francis Group, LLC, 2010. Pg 120-170.
- ^ Hebert DN, Molinari M (October 2007). "In and out of the ER: protein folding, quality control, degradation, and related human diseases". Physiol. Rev. 87 (4): 1377–408. doi:10.1152/physrev.00050.2006. PMID 17928587.
- ^ Russell R (2008). "RNA misfolding and the action of chaperones". Front. Biosci. 13 (13): 1–20. doi:10.2741/2557. PMC 2610265. PMID 17981525. http://www.bioscience.org/2008/v13/af/2557/fulltext.htm.
- ^ Moreau P, Brandizzi F, Hanton S, et al (2007). "The plant ER-Golgi interface: a highly structured and dynamic membrane complex". J. Exp. Bot. 58 (1): 49–64. doi:10.1093/jxb/erl135. PMID 16990376.
- ^ Prudovsky I, Tarantini F, Landriscina M, et al (April 2008). "Secretion Without Golgi". J. Cell. Biochem. 103 (5): 1327–43. doi:10.1002/jcb.21513. PMC 2613191. PMID 17786931. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2613191.
- ^ Zaidi SK, Young DW, Choi JY, Pratap J, Javed A, Montecino M, Stein JL, Lian JB, van Wijnen AJ, Stein GS (October 2004). "Intranuclear trafficking: organization and assembly of regulatory machinery for combinatorial biological control". J. Biol. Chem. 279 (42): 43363–6. doi:10.1074/jbc.R400020200. PMID 15277516.
- ^ Mattick JS, Amaral PP, Dinger ME, Mercer TR, Mehler MF (January 2009). "RNA regulation of epigenetic processes". Bioessays 31 (1): 51–9. doi:10.1002/bies.080099. PMID 19154003.
- ^ Martinez NJ, Walhout AJ (April 2009). "The interplay between transcription factors and microRNAs in genome-scale regulatory networks". Bioessays 31 (4): 435–45. doi:10.1002/bies.200800212. PMC 3118512. PMID 19274664. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3118512.
- ^ Tomilin NV (April 2008). "Regulation of mammalian gene expression by retroelements and non-coding tandem repeats". Bioessays 30 (4): 338–48. doi:10.1002/bies.20741. PMID 18348251.
- ^ Veitia RA (November 2008). "One thousand and one ways of making functionally similar transcriptional enhancers". Bioessays 30 (11–12): 1052–7. doi:10.1002/bies.20849. PMID 18937349.
- ^ Nguyen T, Nioi P, Pickett CB (May 2009). "The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress". J. Biol. Chem. 284 (20): 13291–5. doi:10.1074/jbc.R900010200. PMC 2679427. PMID 19182219. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2679427.
- ^ Paul S (November 2008). "Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches". Bioessays 30 (11–12): 1172–84. doi:10.1002/bies.20852. PMID 18937370.
- ^ Los M, Maddika S, Erb B, Schulze-Osthoff K (May 2009). "Switching Akt: from survival signaling to deadly response". Bioessays 31 (5): 492–5. doi:10.1002/bies.200900005. PMC 2954189. PMID 19319914. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2954189.
- ^ Chesler EJ, Lu L, Wang J, Williams RW, Manly KF (2004). "WebQTL: rapid exploratory analysis of gene expression and genetic networks for brain and behavior". Nat Neurosci 7 (5): 485–86. doi:10.1038/nn0504-485. PMID 15114364. http://www.nature.com/index.html?file=/neuro/journal/v7/n5/full/nn0504-485.html.
- ^ Song Y, Wang W, Qu X, Sun S (February 2009). "Effects of hypoxia inducible factor-1alpha (HIF-1alpha) on the growth & adhesion in tongue squamous cell carcinoma cells". Indian J. Med. Res. 129 (2): 154–63. PMID 19293442.
- ^ Hanriot L, Keime C, Gay N, et al (2008). "A combination of LongSAGE with Solexa sequencing is well suited to explore the depth and the complexity of transcriptome". BMC Genomics 9: 418. doi:10.1186/1471-2164-9-418. PMC 2562395. PMID 18796152. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2562395.
- ^ Wheelan SJ, Martínez Murillo F, Boeke JD (July 2008). "The incredible shrinking world of DNA microarrays". Mol Biosyst 4 (7): 726–32. doi:10.1039/b706237k. PMC 2535915. PMID 18563246. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2535915.
- ^ Miyakoshi M, Nishida H, Shintani M, Yamane H, Nojiri H (2009). "High-resolution mapping of plasmid transcriptomes in different host bacteria". BMC Genomics 10: 12. doi:10.1186/1471-2164-10-12. PMC 2642839. PMID 19134166. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2642839.
- ^ Denoeud F, Aury JM, Da Silva C, et al, F; Artiguenave (2008). "Annotating genomes with massive-scale RNA sequencing". Genome Biol. 9 (12): R175. doi:10.1186/gb-2008-9-12-r175. PMC 2646279. PMID 19087247. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2646279.
- "Genes & Gene Expression". The Virtual Library of Biochemistry and Cell Biology. BioChemWeb.org. 2005-12-04. http://www.biochemweb.org/genes.shtml. Retrieved 2008-06-10.
- John Kryk (2008-05-28). "DNA makes RNA". http://www.johnkyrk.com/DNAtranscription.html. Retrieved 2008-06-10.
- "Advancing Gene Expression Studies". Genetic Engineering & Biotechnology News. Mary Ann Liebert, Inc.. 2008-08-01. http://www.genengnews.com/articles/chitem.aspx?aid=2542.
- "Optimizing Transient Gene Expression". Genetic Engineering & Biotechnology News. Mary Ann Liebert, Inc.. 2008-03-01. http://www.genengnews.com/articles/chitem.aspx?aid=2397.
Gene expression Introduction to genetics Transcription Translation Gene regulation
Wikimedia Foundation. 2010.